Literature DB >> 12106782

CpG DNA: recognition by and activation of monocytes.

Dennis M Klinman1, Fumihiko Takeshita, Ihsan Gursel, Cynthia Leifer, Ken J Ishii, Daniela Verthelyi, Mayda Gursel.   

Abstract

Unmethylated CpG motifs present in bacterial DNA rapidly trigger an innate immune response characterized by the activation of Ig- and cytokine-secreting cells. Synthetic oligonucleotides (ODNs) containing CpG motifs mimic this activity, triggering monocytes to proliferate, secrete and/or differentiate. Analysis of hundreds of novel ODNs led to the identification of two structurally distinct classes of CpG motif that differentially activate human monocytes. ODNs of the "K"-type interact with Toll-like receptor 9 and induce monocytes to proliferate and secrete IL-6. In contrast, "D"-type ODNs trigger monocytes to differentiate into mature dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106782     DOI: 10.1016/s1286-4579(02)01614-3

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

1.  Impact of site-specific nucleobase deletions on the arthritogenicity of DNA.

Authors:  Jan L Bjersing; Andrej Tarkowski; Ekambar R Kandimalla; Helen Karlsson; Sudhir Agrawal; L Vincent Collins
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

2.  Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir.

Authors:  Michael A Kolber; Maria O Saenz; Sameer Kaul
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 3.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

4.  Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.

Authors:  G Pedersen; L Andresen; M W Matthiessen; J Rask-Madsen; J Brynskov
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs.

Authors:  Andrzej Grajkowski; Joao Pedras-Vasconcelos; Vivian Wang; Cristina Ausín; Sonja Hess; Daniela Verthelyi; Serge L Beaucage
Journal:  Nucleic Acids Res       Date:  2005-06-21       Impact factor: 16.971

6.  The effect of CpG-ODN on antigen presenting cells of the foal.

Authors:  M Julia B F Flaminio; Alexandre S Borges; Daryl V Nydam; David W Horohov; Rolf Hecker; Mary Beth Matychak
Journal:  J Immune Based Ther Vaccines       Date:  2007-01-25

7.  A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.

Authors:  Young Mee Yoon; Jamal S Lewis; Matthew R Carstens; Martha Campbell-Thompson; Clive H Wasserfall; Mark A Atkinson; Benjamin G Keselowsky
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

8.  Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART-treated HIV+ subjects.

Authors:  Lance K Blevins; Robert B Crawford; Diana J Azzam; Tomás R Guilarte; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2020-11-17       Impact factor: 6.011

9.  Patterns of evolution and host gene mimicry in influenza and other RNA viruses.

Authors:  Benjamin D Greenbaum; Arnold J Levine; Gyan Bhanot; Raul Rabadan
Journal:  PLoS Pathog       Date:  2008-06-06       Impact factor: 6.823

10.  Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections.

Authors:  Wing Ki Cheng; Adam William Plumb; Jacqueline Cheuk-Yan Lai; Ninan Abraham; Jan Peter Dutz
Journal:  Front Immunol       Date:  2016-07-29       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.